Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Malignant Glioma
Items per page
5
10
20
40
60
100
Title
Average Rating
Tumor pO(2) as a Surrogate Marker to Identify Therapeutic Window during Metronomic Chemotherapy of 9L Gliomas.
60.00%
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial.
70.00%
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
50.00%
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas ...
50.00%
Outside the box--novel therapeutic strategies for glioblastoma.
80.00%
Novel anti-angiogenic therapies for malignant gliomas.
50.00%
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.
70.00%
Chemoradiotherapy in malignant glioma: standard of care and future directions.
50.00%
A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glio....
60.00%
A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination..............
70.00%
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
80.00%
Lessons learned in the development of targeted therapy for malignant gliomas
50.00%